Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges

Yahoo Finance12/11 01:22

Omeros Corporation Presents Phase 2 Zaltenibart Data At ASH Meeting, Supporting Dose Selection For Upcoming Phase 3 Clinical Trials In Paroxysmal Nocturnal Hemoglobinuria, With Enrollment Set For Early 2025

Benzinga12/10 21:46

AppLovin, MicroStrategy, and 28 Other Stocks That Could Be Bubbles

Barrons12/05 00:18

Jim Cramer Prefers FedEx Over This Delivery Giant That 'Screwed Up A Lot Of Holiday Seasons'

Benzinga12/03 23:12

Replimune REPL +35% BLA Submission; Omeros OMER +41% BLA Update

BioPharmCatalyst11/23 08:00

Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday

Benzinga11/22 23:59